Drug
Who makes larotrectinib?
2 companies list larotrectinib as a human prescription drug, including under the names VITRAKVI. Forms: capsule; solution; solution, concentrate. Routes: oral, oropharyngeal.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing larotrectinib
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Bayer Healthcare Manufacturing SrlGermany | capsule; solution, concentrate | NDANDA210861, NDA211710 | 4 | 13 |
| Loxo Oncology, Inc. | capsule; solution | NDANDA210861, NDA211710 | 3 | 0 |
Enquiry
Common questions
- Who makes larotrectinib?
- 2 companies list larotrectinib as a human prescription drug in the openFDA NDC Directory, led by Bayer Healthcare Manufacturing Srl, Loxo Oncology, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.